Jennifer S. Kullmann

Frankfurt Am Main, HE 65926, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

Journal: Therapeutic advances in neurological disorders

Published: December 07, 2023

A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab.

A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab.

Journal: Multiple sclerosis and related disorders

Published: April 11, 2021

Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status.

Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status.

Journal: Therapeutic advances in neurological disorders

Published: March 04, 2021

Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study.

Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study.

Journal: Patient preference and adherence

Published: February 05, 2020

Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study.

Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study.

Journal: Therapeutic advances in neurological disorders

Published: September 21, 2018

Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey.

Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey.

Journal: Therapeutic advances in neurological disorders

Published: July 02, 2016

Towards understanding sex differences in visceral pain: enhanced reactivation of classically-conditioned fear in healthy women.

Towards understanding sex differences in visceral pain: enhanced reactivation of classically-conditioned fear in healthy women.

Journal: Neurobiology of learning and memory

Published: September 10, 2013

Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry study.

Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry study.

Journal: Pain

Published: May 06, 2013

Experimental human endotoxemia enhances brain activity during social cognition.

Experimental human endotoxemia enhances brain activity during social cognition.

Journal: Social cognitive and affective neuroscience

Published: April 03, 2013

Low dose LPS does not increase TLR4 expression on monocytes in a human in vivo model.

Low dose LPS does not increase TLR4 expression on monocytes in a human in vivo model.

Journal: Cytokine

Published: October 27, 2012

Salivary α-amylase response to endotoxin administration in humans.

Salivary α-amylase response to endotoxin administration in humans.

Journal: Psychoneuroendocrinology

Published: September 03, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026